Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

KKR & Co. L.P. (KKR): This Healthcare Unit Is Attracting Attention From Big-Name Bidders

The recent announcement that beleaguered electronics manufacturer Panasonic would solicit bids for its non-core healthcare business has cheered investors and spurred renewed interest in the company’s stock. Although a final timeline for the division’s sale has not yet been established, it was recently announced that the preliminary round of bidding had closed. Panasonic is expected to conduct a follow-up bidding round next month.

Although interest in the division has not been overwhelming, it is clear that Panasonic will not find it difficult to offload the asset. The company has received interest from rival electronics manufacturer Toshiba (NASDAQOTH:TOSBF) and publicly traded private equity giant Kohlberg Kravis Roberts. In addition, a number of privately held capital management firms like Bain Capital and TPG Capital Management have expressed interest in submitting bids as well. Since this deal could produce significant synergies for the division’s eventual buyer and provide Panasonic with a much-needed cash infusion, the next few months promise to be very interesting for the company’s investors.


Comparing the public players: Panasonic, Toshiba, and KKR & Co. L.P. (NYSE:KKR)

Kadoma, Japan-based Panasonic and Tokyo-based Toshiba operate in a number of overlapping sectors of the electronics and computing industries. Although it remains a powerful television and recording-equipment manufacturer, Panasonic has struggled to transition into the realm of cloud-based computing technology and next-generation connectivity equipment. Toshiba has navigated this transition fairly well, but it continues to suffer from poor pricing power and quality-control issues. Obviously, KKR & Co. L.P. (NYSE:KKR) has little in common with either company. Nevertheless, a quick financial comparison between the three firms is warranted.

With market cap figures of $19 billion and $21 billion, respectively, Panasonic and Toshiba are similar in size. Although KKR & Co. L.P. (NYSE:KKR)’s market capitalization of about $5.3 billion makes it considerably smaller, it is important to remember that KKR produces far more revenue per employee. Earnings-wise, Panasonic is clearly suffering more than Toshiba or KKR & Co. L.P. (NYSE:KKR). Its 2012 loss of $9.6 billion on revenue of $92.8 billion produced a profit margin of minus 10.3%. In comparison, Toshiba eked out a profit of $985 million on about $75 billion in total revenue. KKR & Co. L.P. (NYSE:KKR)’s $564 million profit on $8.8 billion in revenue gave it a profit margin of nearly 6.5%.

Panasonic’s cash flow has the potential to make up for its horrendous earnings figures. With an operating cash flow of $4.3 billion, and $6.3 million already in the bank, its long-term debt load of $14.5 billion looks manageable. On the other hand, Toshiba’s $1.7 billion cash flow figure looks shaky next to its $2.7 billion cash hoard and $21 billion debt load. KKR & Co. L.P. (NYSE:KKR)’s $7.4 billion cash flow dwarfs its $1.7 billion debt burden.

How the deal might happen

According to initial reports, the sale of Panasonic’s healthcare division could fetch as much as $1 billion in hard cash. This would be a welcome infusion of liquidity after the company’s crushing 2012 loss. Although the healthcare unit is profitable by a decent margin, it represents a fairly small piece of Panasonic’s overall revenue stream.

As such, the company believes that it will enjoy better long-run health without this non-core business in its portfolio. However, it is unclear whether Panasonic will sell the entire unit in one offering or offload its individual components to interested bidders. It is likely that more information will emerge before the official round of bidding in July.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.